Cargando…
Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature
Background: Precision medicine is based on molecular and genotypic patient characterization to define specific target treatment. BRAF mutation is an oncogenic driver, and the Cancer Genome Atlas has identified BRAF mutations in different cancer types. Tumor type agnostic therapy is based on targetin...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920250/ https://www.ncbi.nlm.nih.gov/pubmed/33669326 http://dx.doi.org/10.3390/ph14020159 |